OPEN END TURBO CALL WARRANT - AMGEN | Real-time Boerse Frankfurt Warrants 09:21:50 04/07/2024 BST | ||
| 1.48 EUR | -1.33% |
|
| Current month | -3.85% | ||
| 1 month | +1.35% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 04/07/24 | 1.48 | -1.33% |
| 03/07/24 | 1.5 | -2.60% |
| 02/07/24 | 1.54 | -0.65% |
| 01/07/24 | 1.55 | -0.64% |
| 28/06/24 | 1.56 | 0.00% |
Real-time Boerse Frankfurt Warrants
Last update July 04, 2024 at 09:21 am
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UH42CC |
| ISIN | DE000UH42CC2 |
| Date issued | 03/12/2021 |
| Strike | 145.6 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 0.62 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.72 € |
|---|---|
| Lowest since issue | 0.57 € |
| Spread | 0.1 € |
| Spread % | 6.33% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
309.4
USD
Average target price
316.4
USD
Spread / Average Target
+2.28%
- Stock Market
- Certificates
- Certificat
